| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.317 | 30.103 | 35.952 | 38.012 | 48.546 | 50.934 | 111.782 | 130.907 | 155.525 | 142.245 |
| Total Income - EUR | 3.317 | 30.103 | 35.952 | 38.012 | 48.546 | 50.934 | 111.782 | 130.910 | 155.525 | 142.245 |
| Total Expenses - EUR | 18.618 | 17.956 | 16.326 | 31.116 | 40.056 | 31.348 | 90.507 | 144.334 | 126.341 | 122.540 |
| Gross Profit/Loss - EUR | -15.301 | 12.147 | 19.626 | 6.896 | 8.489 | 19.587 | 21.275 | -13.424 | 29.184 | 19.705 |
| Net Profit/Loss - EUR | -15.400 | 11.545 | 19.266 | 6.513 | 7.856 | 19.231 | 20.073 | -14.733 | 27.628 | 15.437 |
| Employees | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Triodent Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 137 | 136 | 133 | 131 | 2.953 | 2.621 | 68.816 | 53.166 | 49.108 | 106.953 |
| Current Assets | -10.443 | -1.085 | 4.758 | 7.319 | 8.648 | 21.806 | 23.864 | 10.023 | 29.074 | 31.940 |
| Inventories | 2.524 | 2.063 | 2.592 | 3.823 | 3.923 | 4.376 | 5.369 | 6.895 | 13.682 | 13.605 |
| Receivables | 0 | 111 | 0 | 2.830 | 4.600 | 1.158 | 17.897 | 2.818 | 5.779 | 3.379 |
| Cash | -12.967 | -3.259 | 2.166 | 666 | 126 | 16.272 | 599 | 310 | 9.613 | 14.955 |
| Shareholders Funds | -28.332 | -16.498 | 3.048 | 6.567 | 7.909 | 23.221 | 20.124 | -14.682 | 12.991 | 22.723 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 18.025 | 15.548 | 1.843 | 929 | 3.693 | 1.377 | 72.806 | 78.252 | 65.191 | 116.170 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Triodent Med Srl